Salim, M., Youssef, A., Elshafey, E. (2023). Prevalence of Non-Alcoholic Fatty Liver Disease and Its Association with Severity in Patients with Irritable Bowel Syndrome. The Egyptian Journal of Hospital Medicine, 91(1), 4531-4534. doi: 10.21608/ejhm.2023.296758
Mahmoud labib Mahmoud Salim; Amr Mohamed Fathy Youssef; Eslam Elshafey. "Prevalence of Non-Alcoholic Fatty Liver Disease and Its Association with Severity in Patients with Irritable Bowel Syndrome". The Egyptian Journal of Hospital Medicine, 91, 1, 2023, 4531-4534. doi: 10.21608/ejhm.2023.296758
Salim, M., Youssef, A., Elshafey, E. (2023). 'Prevalence of Non-Alcoholic Fatty Liver Disease and Its Association with Severity in Patients with Irritable Bowel Syndrome', The Egyptian Journal of Hospital Medicine, 91(1), pp. 4531-4534. doi: 10.21608/ejhm.2023.296758
Salim, M., Youssef, A., Elshafey, E. Prevalence of Non-Alcoholic Fatty Liver Disease and Its Association with Severity in Patients with Irritable Bowel Syndrome. The Egyptian Journal of Hospital Medicine, 2023; 91(1): 4531-4534. doi: 10.21608/ejhm.2023.296758
Prevalence of Non-Alcoholic Fatty Liver Disease and Its Association with Severity in Patients with Irritable Bowel Syndrome
Background: In Egypt, irritable bowel syndrome (IBS) and non-alcoholic fatty liver disease (NAFLD) are both common conditions. There has been increased interest in the apparent co-incidence of NAFLD in individuals with IBS as we gain a better understanding of their overlapping risk factors and pathophysiology. The aim: to ascertain the prevalence of NAFLD among IBS patients, as well as the relationship between NAFLD and IBS severity. Patients and methods: A cross-sectional study was conducted on 150 IBS patients who were older than 18 years old at the Hepatology, Gastroenterology, Infectious Diseases Outpatient Clinic and Clinical Pathology Department of Al-Ahrar Zagazig Teaching Hospital. All patients underwent a history taking, general clinical examination, and clinical assessment, imaging studies and laboratory analysis. Results: There were 70.7% people who had NAFLD. 30.2% of patients had severe NAFLD, 19.8% had mild NAFLD, and 50% of patients had intermediate NAFLD. Conclusion: IBS patients have a significant prevalence of NAFLD. In the study participants, moderate/severe NAFLD was a predictor of moderate/severe IBS.